We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+27.94%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$40.4B
AUM Growth
+$6.4B
(+19%)
Cap. Flow
-$900M
Cap. Flow
% of AUM
-2.23%
Top 10 Holdings %
Top 10 Hldgs %
16.03%
Holding
2,489
New
261
Increased
810
Reduced
1,082
Closed
259
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
IBM
IBM
|
+$245M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$143M |
| 3 |
3M
MMM
|
+$142M |
| 4 |
Public Service Enterprise Group
PEG
|
+$108M |
| 5 |
KeyCorp
KEY
|
+$80.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$378M |
| 2 |
Kimberly-Clark
KMB
|
+$186M |
| 3 |
Altria Group
MO
|
+$141M |
| 4 |
AbbVie
ABBV
|
+$141M |
| 5 |
Pfizer
PFE
|
+$120M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.35% |
| 2 | Technology | 19% |
| 3 | Consumer Discretionary | 10.55% |
| 4 | Financials | 9.89% |
| 5 | Communication Services | 7.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
826
Peapack-Gladstone Financial
PGC
$798M
| $3.3M | 0.01% |
176,216
-17,238
| -9% | -$305K |
|
827
LeMaitre Vascular
LMAT
$1.84B
| $3.29M | 0.01% |
124,803
-58,065
| -32% | -$1.52M |
|
828
O-I Glass
OI
$945M
| $3.29M | 0.01% |
367,015
+64,993
| +22% | +$503K |
|
829
Voyager Therapeutics
VYGR
$188M
| $3.28M | 0.01% |
259,943
-217,915
| -46% | -$2.53M |
|
830
Axogen
AXGN
$2.67B
| $3.27M | 0.01% |
+354,137
| New | +$3.17M |
|
831
Elevance Health
ELV
$89.5B
| $3.26M | 0.01% |
12,397
+2,378
| +24% | +$634K |
|
832
KBR
KBR
$4.61B
| $3.23M | 0.01% |
143,067
+107,418
| +301% | +$2.33M |
|
833
Glacier Bancorp
GBCI
$5.85B
| $3.21M | 0.01% |
91,092
+20,687
| +29% | +$767K |
|
|
AIZP
834
DELISTED
Assurant, Inc. 6.50% Series D Mandatory Convertible Preferred Stock, $1.00 par value
AIZP
| $3.19M | 0.01% |
30,640
| – | – |
|
|
TUP
835
DELISTED
Tupperware Brands Corporation
TUP
| $3.19M | 0.01% |
670,461
+106,335
| +19% | +$354K |
|
836
MongoDB
MDB
$30.3B
| $3.18M | 0.01% |
+14,042
| New | +$2.6M |
|
837
Maximus
MMS
$3.02B
| $3.18M | 0.01% |
45,105
-69,249
| -61% | -$4.66M |
|
838
Diodes
DIOD
$4.12B
| $3.16M | 0.01% |
62,362
-15,198
| -20% | -$727K |
|
|
EVA
839
DELISTED
Enviva Inc.
EVA
| $3.14M | 0.01% |
87,060
-12,020
| -12% | -$399K |
|
|
MTSC
840
DELISTED
MTS Systems Corp
MTSC
| $3.11M | 0.01% |
+176,781
| New | +$3.27M |
|
841
CONMED
CNMD
$1.41B
| $3.08M | 0.01% |
42,818
-52,769
| -55% | -$3.67M |
|
842
CoreCivic
CXW
$3.45B
| $3.08M | 0.01% |
328,853
+216,872
| +194% | +$2.47M |
|
843
Dillards
DDS
$10.1B
| $3.07M | 0.01% |
118,893
+114,883
| +2,865% | +$3.25M |
|
|
SRE.PRB
844
DELISTED
Sempra 6.75% Mandatory Convertible Preferred Stock, Series B
SRE.PRB
| $3.07M | 0.01% |
31,201
| – | – |
|
|
SOLN
845
DELISTED
The Southern Company
SOLN
| $3.05M | 0.01% |
69,188
-8,630
| -11% | -$405K |
|
846
Green Dot
GDOT
$756M
| $3.04M | 0.01% |
61,890
-319,628
| -84% | -$10.8M |
|
847
Saic
SAIC
$5.56B
| $3.03M | 0.01% |
38,974
+23,370
| +150% | +$1.92M |
|
848
Anika Therapeutics
ANIK
$279M
| $3.02M | 0.01% |
80,174
+80,138
| +222,606% | +$2.64M |
|
849
NRG Energy
NRG
$22.6B
| $3.02M | 0.01% |
92,602
-8,482
| -8% | -$279K |
|
|
ROCHU
850
DELISTED
Roth CH Acquisition I Co. Unit
ROCHU
| $3.02M | 0.01% |
+300,000
| New | +$3M |
|
Similar funds
Federated Hermes's Q2 2020 Portfolio in Review
As of Q2 2020, Federated Hermes held 2,489 positions worth $40.4B, up 19% from $34B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Federated Hermes's Q2 2020 filing shows 261 new, 810 increased, 1,082 reduced and 259 closed positions. Its largest new stake was ZoomInfo Technologies: 1,084,200 shares worth $55.3M. The largest sale was Gilead Sciences, an estimated $378M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 23% a quarter earlier, followed by Technology and Consumer Discretionary.
- Federated Hermes's largest Q2 2020 buy was ZoomInfo Technologies: 1,084,200 shares worth $55.3M.
- Federated Hermes added most to IBM in Q2 2020, an estimated $245M increase.
- Federated Hermes's biggest Q2 2020 reduction was Gilead Sciences, cutting an estimated $378M.
- Federated Hermes fully exited Invesco in Q2 2020, selling an estimated $62.7M.
- Federated Hermes's ten largest holdings make up 16% of its $40.4B portfolio in Q2 2020.
- Federated Hermes opened 261 new positions and closed 259 in Q2 2020.
- Federated Hermes's portfolio value rose 19% quarter-over-quarter to $40.4B.
Based on Federated Hermes's 13F filing for Q2 2020, filed 13 Aug 2020.